CA1073453A - Process for the preparation of derivatives of prostanoic acid - Google Patents
Process for the preparation of derivatives of prostanoic acidInfo
- Publication number
- CA1073453A CA1073453A CA229,821A CA229821A CA1073453A CA 1073453 A CA1073453 A CA 1073453A CA 229821 A CA229821 A CA 229821A CA 1073453 A CA1073453 A CA 1073453A
- Authority
- CA
- Canada
- Prior art keywords
- que
- formule
- méthyle
- pour obtenir
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002360 preparation method Methods 0.000 title abstract description 3
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 claims description 11
- 238000007254 oxidation reaction Methods 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims 6
- NJJNWEJOWXWBBX-OALUTQOASA-N 7-[(1r,2s)-2-oct-1-enylcyclopentyl]hept-5-enoic acid Chemical compound CCCCCCC=C[C@H]1CCC[C@@H]1CC=CCCCC(O)=O NJJNWEJOWXWBBX-OALUTQOASA-N 0.000 claims 4
- 239000000470 constituent Substances 0.000 claims 2
- 229920002554 vinyl polymer Polymers 0.000 claims 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- DSWICQDUYHOEPQ-UHFFFAOYSA-N [Mg]C=C Chemical compound [Mg]C=C DSWICQDUYHOEPQ-UHFFFAOYSA-N 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- 208000001953 Hypotension Diseases 0.000 abstract description 2
- 230000009471 action Effects 0.000 abstract description 2
- 208000021822 hypotensive Diseases 0.000 abstract description 2
- 230000001077 hypotensive effect Effects 0.000 abstract description 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 230000001595 contractor effect Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- HJHVQCXHVMGZNC-JCJNLNMISA-M sodium;(2z)-2-[(3r,4s,5s,8s,9s,10s,11r,13r,14s,16s)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate Chemical compound [Na+].O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C HJHVQCXHVMGZNC-JCJNLNMISA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 241000370685 Arge Species 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- 241001331845 Equus asinus x caballus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000845077 Iare Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 101100166793 Mus musculus Cela2a gene Proteins 0.000 description 1
- ZJMZZNVGNSWOOM-UHFFFAOYSA-N N-(butan-2-yl)-N'-ethyl-6-methoxy-1,3,5-triazine-2,4-diamine Chemical compound CCNC1=NC(NC(C)CC)=NC(OC)=N1 ZJMZZNVGNSWOOM-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000212342 Sium Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 241001080024 Telles Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- -1 hydroxyimino Chemical group 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7421424A FR2275438A1 (fr) | 1974-06-20 | 1974-06-20 | Procede de preparation de derives de l'acide prostanoique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1073453A true CA1073453A (en) | 1980-03-11 |
Family
ID=9140296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA229,821A Expired CA1073453A (en) | 1974-06-20 | 1975-06-20 | Process for the preparation of derivatives of prostanoic acid |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS5134130A (xx) |
| CA (1) | CA1073453A (xx) |
| CH (1) | CH605730A5 (xx) |
| DK (1) | DK279575A (xx) |
| ES (1) | ES438695A1 (xx) |
| FR (1) | FR2275438A1 (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4498523A (en) * | 1983-05-12 | 1985-02-12 | Aluminum Company Of America | Continuous method for reclaiming, melting and casting aluminum scrap |
| IT1226969B (it) * | 1984-01-05 | 1991-02-26 | Istituto Biochimico Italiano | Procedimento perfezionato per la preparazione dell'acido 7-(2)esil-5- idrossi- ciclopentil)-eptanoico |
| JPS61133334A (ja) * | 1984-11-30 | 1986-06-20 | Hitachi Cable Ltd | 銀の回収方法 |
| JPH01188637A (ja) * | 1988-01-21 | 1989-07-27 | Shintouyou Kinzoku Kogyo Kk | アルミニウム缶屑の処理方法 |
-
1974
- 1974-06-20 FR FR7421424A patent/FR2275438A1/fr active Granted
-
1975
- 1975-06-19 CH CH801175A patent/CH605730A5/xx not_active IP Right Cessation
- 1975-06-19 JP JP7380575A patent/JPS5134130A/ja active Pending
- 1975-06-19 ES ES438695A patent/ES438695A1/es not_active Expired
- 1975-06-20 CA CA229,821A patent/CA1073453A/en not_active Expired
- 1975-06-20 DK DK279575A patent/DK279575A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES438695A1 (es) | 1977-04-01 |
| FR2275438A1 (fr) | 1976-01-16 |
| DK279575A (da) | 1975-12-21 |
| JPS5134130A (ja) | 1976-03-23 |
| CH605730A5 (xx) | 1978-10-13 |
| FR2275438B1 (xx) | 1978-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5004752A (en) | Novel 9-haloprostaglandins, processes for their preparation, and their use as medicinal agents | |
| FR2482097A1 (fr) | Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant | |
| CA1073453A (en) | Process for the preparation of derivatives of prostanoic acid | |
| EP0206899B1 (fr) | Procédé de fabrication de (méth)acrylates d'alkyles fluorés | |
| JP4440506B2 (ja) | ケミカルプロセス | |
| CA1080242A (fr) | Procede de preparation de la vitamine a a partir de sulfones | |
| CA1140110A (fr) | Procede de preparation de nouveaux derives de l'androst-4-ene | |
| EP0520879B1 (fr) | Nouveaux stéroides 16-méthyl substitués dérivés de la pregna 1,4-diène 3,20-dione, leur préparation, leur application à la préparation de steroides 16-méthylène et nouveaux intermédiaires | |
| FR2571369A1 (fr) | Derives de la vitamine d et precurseurs de ceux-ci et compositions pharmaceutiques en contenant | |
| CA2089469A1 (fr) | Composes (meth)acryliques, leur procede de preparation et leur application a la synthese de nouveaux polymeres | |
| CH648329A5 (fr) | Procede de preparation de steroides. | |
| CA2460358A1 (en) | Hydroxyfattysulfonic acid analogs | |
| EP0679629B1 (fr) | Procédé de préparation d'un acide alpha-(hydroxyphenoxy)-alcanecarboxylique optiquement actif et de ses dérivés | |
| CA1087614A (fr) | Procede de preparation de la prostaglandine a.sub.2 et de certains de ses derives | |
| EP0059659B1 (fr) | Nouveaux dérivés de l'acide 4-méthyl 3-formyl pentanoique, leur procédé de préparation et leur application à la préparation de dérivés cycliques | |
| FR2534917A1 (fr) | Epoxycarbacyclines, leur procede de preparation et leur application | |
| JPH038337B2 (xx) | ||
| FR2481277A1 (fr) | Analogues de la prostaglandine e et compositions pharmaceutiques les contenant | |
| EP0100717B1 (fr) | Procédé de synthèse d'alphaalkyl amino aldéhydes | |
| CA1181413A (fr) | Derives cyclopropane-1-carboxyliques et leurs sels, preparation et application a la synthese d'intermediaires de pyrethrinoides cis | |
| FR2479192A1 (fr) | Procede de preparation de derives cyclopropaniques tetra-substitues | |
| EP0184572B1 (fr) | Procédé de préparation d'acides alpha-hydroxy-alcanoiques | |
| CA1027930A (en) | Preparation of a new triene steroid derivative | |
| CH627193A5 (xx) | ||
| EP0058591B1 (fr) | Procédé d'épimérisation d'acides trans chrysanthémiques et nouveaux intermédiaires obtenus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |